Private Trust Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Private Trust Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$426K	Sell	2,691 -21	-0.8%	-$2.84K	0.03%	522
2026 Q1	$346K	Sell	2,712 -44	-2%	-$5.49K	0.03%	565
2025 Q4	$336K	Buy	2,756 +126	+5%	+$14.4K	0.03%	565
2025 Q3	$264K	Sell	2,630 -237	-8%	-$21.3K	0.02%	640
2025 Q2	$238K	Buy	2,867 +33	+1%	+$2.63K	0.02%	664
2025 Q1	$230K	Buy	2,834 +186	+7%	+$16.6K	0.02%	666
2024 Q4	$238K	Sell	2,648 -268	-9%	-$26K	0.02%	624
2024 Q3	$288K	Buy	2,916 +2,410	+476%	+$237K	0.03%	573
2024 Q2	$46.9K	Buy	506 +50	+11%	+$4.48K	0.01%	1139
2024 Q1	$43.3K	Buy	456 +33	+8%	+$3.06K	﹤0.01%	1160
2023 Q4	$37.8K	Sell	423 -525	-55%	-$39K	﹤0.01%	1156
2023 Q3	$69.2K	Sell	948 -595	-39%	-$47.5K	0.01%	913
2023 Q2	$128K	Hold	1,543	–	–	0.02%	721
2023 Q1	$118K	Sell	1,543 -75	-5%	-$6.22K	0.02%	714
2022 Q4	$134K	Sell	1,618 -101	-6%	-$8.18K	0.02%	637
2022 Q3	$136K	Buy	1,719 +593	+53%	+$50K	0.02%	577
2022 Q2	$84K	Buy	+1,126	New	+$84.5K	0.01%	749
2021 Q4	–	Sell	-1,705	Closed	-$214K	–	410
2021 Q3	$214K	Buy	1,705 +52	+3%	+$6.7K	0.03%	382
2021 Q2	$224K	Sell	1,653 -25	-1%	-$3.29K	0.03%	378
2021 Q1	$227K	Sell	1,678 -414	-20%	-$62K	0.04%	364
2020 Q4	$294K	Sell	2,092 -10	-0.5%	-$1.28K	0.05%	316
2020 Q3	$234K	Buy	2,102 +133	+7%	+$14.9K	0.05%	333
2020 Q2	$222K	Buy	+1,969	New	+$194K	0.05%	328
2014 Q4	–	Sell	-60	Closed	-$3K	–	1202
2014 Q3	$3K	Hold	60	–	–	﹤0.01%	1508
2014 Q2	$3K	Sell	60 -333	-85%	-$15K	﹤0.01%	1513
2014 Q1	$19K	Sell	393 -117	-23%	-$5.99K	0.01%	755
2013 Q4	$22K	Buy	510 +60	+13%	+$2.48K	0.01%	682
2013 Q3	$19K	Hold	450	–	–	0.01%	688
2013 Q2	$16K	Buy	+450	New	+$15.8K	0.01%	697

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Private Trust Company's XBI Position: Q2 2026 in Review

Private Trust Company reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.77% in Q2 2026, selling an estimated $2.84K and leaving 2,691 shares worth $426K. The position accounts for 0.03% of the portfolio, ranked #522.

Private Trust Company first reported a position in XBI in Q2 2013 and has held it in 29 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Private Trust Company held 2,691 shares of State Street SPDR S&P Biotech ETF worth $426K as of Q2 2026.
Private Trust Company sold 21 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.84K.
State Street SPDR S&P Biotech ETF made up 0.03% of Private Trust Company's portfolio in Q2 2026, its #522 holding.
Private Trust Company first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 29 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.